Cheyne Capital Management (UK)’s EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant EQHA.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-45,844
Closed -$454K 135
2021
Q1
$454K Buy
+45,844
New +$465K 0.29% 86

Other funds holding EQHA.U

Cheyne Capital Management (UK)'s EQHA.U Position: Q2 2021 in Review

Cheyne Capital Management (UK) sold out of EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant (EQHA.U) in Q2 2021, closing a stake of 45,844 shares — an estimated $454K sold.

Cheyne Capital Management (UK) first reported a position in EQHA.U in Q1 2021 and held it in 1 quarter. The position peaked at $454K in Q1 2021. 43 funds tracked by Wall St. Rank hold EQHA.U as of Q2 2021.

  • Cheyne Capital Management (UK) reported no remaining EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant position as of Q2 2021 after selling out during the quarter.
  • Cheyne Capital Management (UK) sold 45,844 EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant shares in Q2 2021, an estimated $454K.
  • Cheyne Capital Management (UK) first reported a position in EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant in Q1 2021 and held it in 1 quarter.
  • Cheyne Capital Management (UK)'s EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant position peaked at $454K in Q1 2021.
  • 43 funds tracked by Wall St. Rank held EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant as of Q2 2021.

Based on Cheyne Capital Management (UK)'s 13F filing for Q2 2021, filed 12 Aug 2021.